Motus GI Receives Approval from the Israeli Ministry of Health to Initiate Commercial Sales of its Pure-Vu® EVS System
FORT LAUDERDALE, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
FORT LAUDERDALE, Fla., Aug. 10, 2023 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
CINCINNATI, Aug. 10, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the…
CINCINNATI, Aug. 10, 2023 (GLOBE NEWSWIRE) — Blue Water Biotech, Inc. (“Blue Water” or the…
– GeneFab’s cGMP facility in the San Francisco Bay Area has available capacity to support…
– GeneFab’s cGMP facility in the San Francisco Bay Area has available capacity to support…
– Celadon Partners to acquire Senti’s manufacturing facility and CMC capabilities to establish GeneFab, an…
– Celadon Partners to acquire Senti’s manufacturing facility and CMC capabilities to establish GeneFab, an…
FREMONT, CA, Aug. 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
FREMONT, CA, Aug. 10, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…
PharmAla Continues to Support Clinical Trials as the Foremost Supplier of GMP LaNeo MDMA in…
PharmAla Continues to Support Clinical Trials as the Foremost Supplier of GMP LaNeo MDMA in…
Arcutis to receive $30 million upfront payment and is eligible to receive potential development and…
Arcutis to receive $30 million upfront payment and is eligible to receive potential development and…
Introduced next-generation oral KIT inhibitor product candidate THB335, which retains the potency and selectivity of…
Introduced next-generation oral KIT inhibitor product candidate THB335, which retains the potency and selectivity of…
AUSTIN, Texas, Aug. 10, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
AUSTIN, Texas, Aug. 10, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
Prior Approval Supplement (PAS) for VOQUEZNA® TRIPLE PAK® and VOQUEZNA® DUAL PAK® assigned a Prescription…
Prior Approval Supplement (PAS) for VOQUEZNA® TRIPLE PAK® and VOQUEZNA® DUAL PAK® assigned a Prescription…
Phase 2a data published in The Lancet’s eBioMedicine supports further development of UB-311 The paper…